Business · Companies · 3 hrs ago
Pointers PE plans 15 billion won investment in South Korea's Remed
South Korean investment firm Pointers PE plans to invest 15 billion won in Remed, a medical-device company listed on the KOSDAQ market.
The investment, made with LF Investment, is planned as 5 billion won for existing shares and a 10 billion won convertible bond.
The deal would provide Remed with new growth funding while allowing some existing shareholders to sell shares.
Remed makes medical devices, including magnetic-field equipment used for chronic pain treatment, and nearly 70% of its recent revenue came from pain management and muscle stimulation.
Pointers PE sees room to expand Remed's business as demand grows for pain care and non-invasive treatment, and as interest rises in managing muscle health alongside GLP-1 weight-loss treatments.
The firm says it will use its international business and investment networks to seek partnerships and improve how Remed's products are used in different markets.
Its next step is to pursue that growth strategy, although the source does not give a completion date for the investment.
Pointers Private Equity plans to invest 15 billion won in South Korean medical-device company Remed.
The proposed investment combines 5 billion won in existing shares and 10 billion won in new convertible bonds.
The investment is being made through a fund jointly managed by Pointers PE and LF Investment.
Pointers PE said it plans to use its global business and capital networks to support Remed’s growth after the investment.
Remed’s main business includes magnetic-field devices for chronic pain treatment and muscle stimulation.
- Who
- Pointers Private Equity plans to invest in Remed, a South Korean medical-device company.
- What
- It plans a 15 billion won investment, combining existing shares and new convertible bonds.
- When
- The plan was reported on October 21, 2026.
- Where
- South Korea. Remed is listed on KOSDAQ.
- Why
- Pointers PE sees growth potential in Remed’s medical devices and plans to support its global business development.
This story does not have two clearly opposing sides.
Pointers PE said it planned the 15 billion won investment in Remed.
Pointers PE plans to pursue a value-creation strategy using its global business and capital networks.
- Total planned investment
- 15 billion won
- Existing shares
- 5 billion won
- New convertible bonds
- 10 billion won
- Fund
- Dr.Tech No. 1 New Technology Investment Partnership, jointly managed by Pointers PE and LF Investment
- Remed listing
- KOSDAQ
What people are saying
To realize a company's growth potential, it is important to combine management's capabilities with global industry networks, capital and strategic partnerships.
We will provide growth resources that companies may find difficult to secure on their own, design investment structures that meet market expectations and pursue substantive value creation.